Epac is a guanine nucleotide exchange protein that is directly activated by cAMP, but whose cardiac cellular functions remain unclear. It is important to understand cardiac Epac signaling, because it is activated in parallel to classical cAMP-dependent signaling via protein kinase A. In addition to activating contraction, Ca 2+ is a key cardiac transcription regulator (excitationtranscription coupling [Ca 2+ ] n during both diastole and systole, correlating with the perinuclear expression pattern of Epac. Moreover, Epac activation induced histone deacetylase 5 (HDAC5) nuclear export, with consequent activation of the prohypertrophic transcription factor MEF2. These data provide the first evidence that the cAMP-binding protein Epac modulates cardiac nuclear Ca 2+ signaling by increasing [Ca 2+ ] n through PLC, IP 3 R and CaMKII activation, and initiates a prohypertrophic program via HDAC5 nuclear export and subsequent activation of the transcription factor MEF2.
Introduction
Ca 2+ is a key element in cardiac excitation-contraction (EC) coupling. In each heartbeat, membrane depolarization during an action potential activates L-type Ca 2+ channels located in the sarcolemma. Ca 2+ entry through these channels activates intracellular Ca 2+ release channels, named ryanodine receptors (RyRs), which are located in the membrane of the sarcoplasmic reticulum (SR). RyRs amplify the initial Ca 2+ signal via Ca 2+ -induced Ca 2+ release (CICR), providing enough Ca 2+ to activate contractile myofibrils. Relaxation then occurs when intracellular Ca 2+ concentration ([Ca 2+ ] i ) returns to diastolic values, due mainly to Ca 2+ pumped back into the SR by the Ca 2+ -ATPase (SERCA) and extrusion from the cell via Na + /Ca 2+ exchange (NCX). [1] While Ca 2+ in EC coupling is physiologically and pathophysiologically relevant, new roles for cardiac myocyte Ca 2+ are being elucidated. For instance, prohypertrophic signaling seems to be activated by perinuclear activation of CaMKII promoted by local elevation of nuclear [Ca 2+ ] ([Ca 2+ ] n ). [2] By analogy to EC coupling, this process has been named excitation-transcription (ET) coupling. However, it is still not fully understood how [Ca 2+ ] n variations may be dissociated from bulk [Ca 2+ ] i oscillations during contraction-relaxation cycles. We recently showed that Epac (exchange protein directly activated by cAMP) could activate SR Ca 2+ release in ventricular myocytes, via a CaMKII-dependent phosphorylation of the RyR [3] , and we hypothesized that Epacdependent Ca 2+ signaling may also be implicated in cardiac hypertrophy. [4, 5] Epac induces cardiomyocyte hypertrophy, both in cultured neonatal ventricular myocytes [4] and in adult myocytes. [5] Epac is a guanylyl exchange protein (GEF) [6, 7] widely distributed in the organism, including the heart, whose functional roles are just beginning to be defined. [8, 9] The hypertrophic effects of Epac are independent of the classical effector of cAMP, protein kinase A (PKA), but rather involve the Ca 2+ /calmodulin-dependent protein kinase II (CaMKII). [5] In addition, Epac expression is increased in experimental animal models of cardiac hypertrophy [10] and contributes to the hypertrophic effect of β-adrenergic receptor. [5] CaMKII is also known to activate nuclear export of class II histone deacetylases (e.g. HDAC4 and 5), [2, 11] an effect which derepresses myocyte enhancer factor 2 (MEF2) driven transcription, and contributes to hypertrophic remodeling.
Here we dissected the signaling pathway linking Epac activation to Ca 2+ mobilization, paying a special attention to [Ca 2+ ] n , and activation of HDAC5 nuclear export. By simultaneously analyzing cytoplasmic and [Ca 2+ ] n during selective Epac activation with 8-pCPT-2′-O-Me-cAMP (8-pCPT), we found that Epac preferentially and differently increases [Ca 2+ ] n (more than bulk [Ca 2+ ] i ). This action involves phospholipase C (PLC)/Inositol 1,4,5-trisphosphate (IP 3 ) signaling and CaMKII activation. In addition, we found that Epac induced HDAC5 export via activation of IP 3 R and CaMKII, and results in activation of the hypertrophic transcription factor MEF2.
Methods
All experiments were carried out according to the ethical principles laid down by the French (Ministry of Agriculture) and European Union Council Directives for the care of laboratory animals.
Cell isolation and Ca 2+ imaging
Ventricular cardiomyocytes from Wistar rats (250-300 g) were isolated using a standard enzymatic digestion as previously described. [12] Only rod-shaped cells, quiescent when unstimulated and excitable were used for the Ca 2+ experiments.
[Ca 2+ ] i transients and Ca 2+ sparks were recorded in intact myocytes loaded with fluorescent Ca 2+ dye (Fluo-3 AM) [13] To record Ca 2+ fluorescence in the Ca 2+ stores (SR and nuclear envelope) cells were loaded with the low-affinity Ca 2+ dye Mag-Fluo-4 AM (6μMol/L) at 37°C for 60 min allowing the compartmentalization of the dye for intra store [Ca 2+ ] i measurements.
Images were obtained with confocal microscopy (Meta Zeiss LSM 510, objective w.i. 63x, n.a. 1.2) by scanning the cell with an Argon laser every 1.54 ms; fluorescence was excited at 488 nm and emissions were collected at >505 nm. Image analyses were performed by homemade routines using IDL software (Research System Inc.). Images were corrected for the background fluorescence. Ca 2+ sparks were detected using an automated detection system and a criterion that limited the detection of false events while detecting most Ca 2+ sparks. [14] 
Cardiac myocytes transfection
For HDAC5 transfection, isolated adult rat cardiomyocytes were seeded on laminin-coated glass coverslips and cultured in a PC-1™ complete serum-free medium (Lonza) completed with penicillin (5%) and streptomycin (5%). Nonadherent cells were removed after 30-45 min. The myocytes were then exposed overnight to recombinant replication-deficient adenovirus expressing HDAC5-GFP (100 multiplicities of infection). HDAC5-GFP signal was studied in control condition, under endothelin-1 (ET-1) (100 nmol/L) and upon 8-pCPT (10 μmol/L) exposure. HDAC5-GFP signals were assessed every 10 minutes for 60 minutes by confocal microscopy (Zeiss LSM 5 Live, objective o.i. 40x). Image-J software was used for image analysis.
For MEF2 activity, neonatal rat ventricular myocytes were isolated. [15] Transient transfection experiments were performed with Lipofectamine 2000 (Invitrogen Life Technologies, France) in optimum medium in the presence of 1 μg of the plasmid constructs according to the manufacturers' instructions. The Epac1 plasmid construct and 3xMEF2-luciferase reporter gene (MEF2-Luc) constructs were provided by Dr. J. Bos (University of Utrecht, The Netherlands) and Dr K.C. Wollert (Hanover Medical School, Germany), respectively.
Immunolabeling
Freshly isolated adult cadiomyocytes were fixed in 4% paraformaldehyde for 10 min and washed two times in phosphate buffered saline (PBS) solution for 15 min. Myocytes were incubated in a solution of 1% bovine serum albumin (BSA) and 5 mg/mL saponin in PBS for 1h at room temperature (RT). Myocytes were incubated with anti-Epac antibody (1:100, Santa Cruz Biotechnology, Inc) in PBS solution with 1% BSA overnight at 4°C. Then myocytes were washed 4 times every 30 min with 1% BSA in PBS solution and incubated with the secondary antibody goat anti-rabbit Alexa 488 in the same solution for 2 hours at RT. 4′,6′-diamidino-2′-phenylindoladihydrochloride (DAPI) was used as nuclear counterstain and was added to the secondary antibody solution in a final concentration of 1 μg/mL. After a serial of washes (first every 30 min for 2 times with 1% BSA in PBS solution, and later 2 times 15 min each in PBS), samples were mounted on glass slides in Slow Fade Lite (Invitrogen Corp.). For negative control we used the same protocol omitting the primary antibody in the solution. Images were recorded using confocal microscopy (Meta Zeiss LSM 510, objective w.i. 63x). Alexa fluorescence was excited by the 488nm line of an Argon laser and emission collected through a BP filter (505-530 nm). DAPI fluorescence was excited by the Hg lamp (BP 365/12) and emission collected through a BP filter (480-520 nm).
Immunoblot
Adult cardiac myocytes treated or not with 8-pCPT were lysed in a buffer containing 50 mmol/L Tris pH 7.5, 500 mmol/L NaCl, 20 mmol/L MgCl2, 1% Triton X-100, 0.5% deoxycholic acid, 0.1 % sodium dodecyl sulphate (SDS), and protease inhibitors (1 mmol/L Phenylmethylsulphonylfluoride, 10 μg/L aprotinine, 10 μg/L leupeptin). After centrifugation for 20 min at 15000 g, proteins were denaturated in Laemmli's buffer (10 min, 37°C), separated on SDS-polyacrylamide gel electrophoresis, and transferred onto a polyvinylidene difluoride membrane (Hybond-P; GE Healthcare). Membranes were hybridized overnight at 4°C with the primary antibody against phosphorylated RyR at Ser2815 site (gift from Dr. A.R. Marks [16] ) or RyR (Affinity BioReagents).
Chemical products
8-pCPT was purchased from Sigma and used at a final concentration of 10 μmol/L. CaMKII inhibitor KN93 (1 μmol/L) was purchased from Calbiochem and PLC inhibitor U73122 (2 μmol/L) from Tocris. IP 3 R antagonist 2-aminoethoxydiphenyl borate (2-APB) (2 μmol/L) and PKC inhibitor chelerythrine (2 μM) were purchased from Sigma.
Statistical analysis
Data are presented as means±SEM. Statistical significance was evaluated by analysis of Studentś t-test paired or unpaired whenever appropriate. Differences with values of p<0.05 were considered statistically significant.
Results

Epac effect on intracellular Ca 2+
To simultaneously analyze Epac effects on cytosolic ([Ca 2+ ] i ) and [Ca 2+ ] n , fluo-3 loaded isolated adult ventricular myocytes field-stimulated at 1 Hz were subjected to line scans including the nucleus, and normalized to the diastolic fluorescence in each compartment (F 0 ) [17] . We are not comparing [ Figure 1A shows representative line scan images from a cardiomyocyte paced (1 Hz) before (left) and during (right) 8-pCPT exposure to selectively activate Epac. [18] Figure 1B (Fig. 1D ). In the nucleus, this combination of effects (increase of both, diastolic and systolic [Ca 2+ ] n ) resulted in no significant change in the amplitude of the [Ca 2+ ] n transient (Fig. 1C) . The overall elevation of [Ca 2+ ] n in response to 8-pCPT (both diastolic and peak) (Fig. 1D ) suggests a preferential effect of 8-pCPT on nuclear vs. cytoplasmic [Ca 2+ ], which may influence nuclear Ca 2+ -dependent signaling. Similar data were observed with 10 fold lower 8-pCPT concentration (supplementary Fig. S2) 
Mechanism of Epac effect on Diastolic and Systolic [Ca 2+ ] i
In assessing the mechanism of Epac induced alterations in Ca 2+ signaling, we monitored both diastolic and systolic [Ca 2+ ] i simultaneously at 1Hz stimulation (Fig. 2) . Although fluo-3 is non-ratiometric, data were collected in the same cell before and during 8-pCPT application, allowing assessment of Epac effects on [Ca 2+ ] i (i.e. normalization vs. the same cell before Epac activation). A time control without Epac activation shows that the [Ca 2+ ] i signals were stable during the 5-7 min recording period ( Fig. 2A-B, light grey bars) . Epac can activate phospholipase C (PLC) in mouse cardiomyocytes [19] , and that could mediate these effects via consequent PKC and IP 3 activation. Moreover, IP 3 R are concentrated at the nuclear envelope [20] and associated with CaMKII in ventricular myocytes. [21] These pathways were tested.
We observed that Epac activation significantly increased diastolic [Ca 2+ ] i ( Fig. 2A) , and this effect was completely prevented by inhibition of either phospholipase C (PLC; by 2 μM U73122), the IP 3 R (by 2 μM 2-aminoethoxydiphenyl borate, 2-APB), or CaMKII (by 1 μM KN-93). Inhibition of protein kinase C (PKC by 2 μmol/L chelerytrine [22] ) partially, but incompletely inhibited the Epac-induced elevation of diastolic [Ca 2+ ] i ( Fig. 2A) . These results suggest that Epac-induced elevation of diastolic [Ca 2+ ] i may be attributable to activation of PLC, IP 3 R and CaMKII (with possible involvement of PKC). Similar results were obtained in quiescent cells: 8-pCPT treatment induced an increase on resting Ca 2+ fluorescence by 23.25% (p<0.05, n=14) that was inhibited in the presence of PLC blocker (5.63% increase, N.S., n=9), or in the presence of IP 3 R blocker (1.23% increase, N.S., n=14), and CaMKII blocker (0.72% increase, N.S., n=13). This increase in resting Ca 2+ was maintained in the presence of the PKC blocker (29.8%, p<0.05, n=9). The increase in diastolic [Ca 2+ ] i is likely not due to an increase in Ca 2+ entry. The main Ca 2+ entry pathway in cardiac myocytes are the L-type Ca 2+ channels and we [3] and others [23] previously showed that 8-pCPT did not modified the L type Ca 2+ current. Although not prominent in these cells, store-operated Ca 2+ entry (SOCE) may exist in cardiac myocytes and could contribute to Epac effects. This hypothesis was tested but, under our conditions, 8-pCPT failed to induce Ca 2+ entry through SOCE (data not shown).
Epac has the opposite effect on systolic [Ca 2+ ] i , showing a reduction within 2-3 min of 8-pCPT application (Fig. 2B) . Both PLC and CaMKII inhibition prevented the 8-pCPTinduced decrease in systolic [Ca 2+ ] i (Fig. 2B) , while PKC and IP 3 R inhibition did not prevent the Epac-dependent reduction of systolic [Ca 2+ ] i . Taken together, these data suggest that Epac-induced activation of PLC and CaMKII seem to be important in both the diastolic and systolic [Ca 2+ ] i modulation, while the IP 3 R are more centrally involved in the diastolic [Ca 2+ ] i increase.
Ca 2+ sparks
The 8-pCPT-induced increase of diastolic [Ca 2+ ] i may be due to increased SR Ca 2+ leak through RyRs, but could also be secondary to slowed [Ca 2+ ] i decline [3] (Supplemental Fig.  S1 ) during the [Ca 2+ ] i transient or alterations in trans-sarcolemmal Ca 2+ fluxes. Epac activation did not alter the rate of Ca 2+ extrusion via Na + /Ca 2+ exchange or Ca 2+ influx via Ca 2+ current, but can increase diastolic Ca 2+ sparks in a CaMKII-dependent manner.
[3] Figure 3A shows line scan images of Ca 2+ sparks recorded in control conditions after drug preincubation (top) and in the same cells during application of 10 μmol/L 8-pCPT (bottom). The expected increase in Ca 2+ spark frequency [3] was completely prevented by PLC inhibition (Fig. 3B) , but not by PKC inhibition, consistent with the effects on diastolic Fig. 3C ), and its effect was blocked by either PLC inhibition (Fig. 3C) or CaMKII inhibition [3] , thus being consistent with systolic [Ca 2+ ] i .
Taken together, these data show that PLC, CaMKII and possibly IP 3 /IP 3 R, but not PKC signaling are involved in the Epac-induced increase of Ca 2+ spark occurrence. This is similar to the conclusions taken from Epac effects on diastolic [Ca 2+ ] i . A working hypothesis could be that Epac activates PLC and IP 3 production, which causes release of Ca 2+ via IP 3 R and consequent activation of local CaMKII to induce RyR phosphorylation thereby increasing Ca 2+ spark frequency. In favor of this hypothesis, 8-pCPT induced RyR phosphorylation at the CaMKII site (Ser2815) which was blocked by the PLC inhibitor, U73122 (Supplemental Fig. S3 ).
Nuclear Epac and [Ca 2+ ] n
To further analyze the effects of Epac activation on [Ca 2+ ] n during continuous field stimulation at 1Hz, we measured diastolic, systolic and time-averaged [Ca 2+ ] n during 8-pCPT exposure (Fig. 4A) . The Epac-dependent increase in [Ca 2+ ] n was prevented by the IP 3 R blocker, 2APB, and by the CaMKII inhibitor, KN93.
As shown in Figure 1 , Epac effects [Ca 2+ ] n more than [Ca 2+ ] i , and this seems to involve IP 3 R activation (see above). Moreover, 8-pCPT promoted IP3 production ( Supplementary  Fig. S4 ). Since IP 3 Rs in adult ventricular cells are concentrated in the nuclear envelope and/ or perinuclear regions [20, 21, 24] , we tested whether Epac localization is also perinuclear, as previously suggested. [4, 5, 25] We assessed endogenous Epac localization in freshly isolated adult ventricular cardiomyocytes by immunolabeling. Figure 4B shows fluorescence images obtained from an adult cardiac myocyte double labeled with Epac antibody (top) and DAPI to localize the nuclei (middle). Epac fluorescence is seen over the background as bright dots, which were absent in negative controls (Fig. 4C) . The signal showed a preferential nuclear/perinuclear localization. The nuclear envelope may act as a Ca 2+ reservoir and it is enriched in IP 3 Rs. We monitored Ca 2+ stored in the nuclear envelope during 8-pCPT application (Fig 4D-E) . Although Mag-fluo is both a Ca 2+ and Mg 2+ indicator, it is currently used as low sensitivity Ca 2+ dye to image Ca 2+ in intracellular stores. We observed that the nuclear envelope [Ca 2+ ] decreased with respect to the SR [Ca 2+ ] during Epac activation, indicating proportionally higher Ca 2+ release from the nuclear envelope than from the SR.
The Epac-induced elevation of [Ca 2+ ] n and CaMKII, and prohypertrophic effect of Epac [5] raises the question whether this IP 3 and CaMKII-dependent nuclear signaling is involved in regulating Ca 2+ -dependent transcription factors.
Effect of Epac on transcription factors
We tested whether Epac could induce HDAC5 nuclear export in an IP 3 -and CaMKIIdependent manner. Rat myocytes were infected with an adenovirus coding for GFP-HDAC5. Figure 5A -B shows that 8-pCPT induced HDAC5 translocation out of the nucleus (seen as a reduction in nuclear to cytosolic fluorescence). The extent and time course were similar to that seen for endothelin 1 (ET-1) used as positive control (Fig. 5B) . Epac also increased MEF2 transcriptional activity in primary neonatal cardiac myocytes (Fig. 5C) . Finally, we found that inhibiting either CaMKII or IP 3 R blocked 8-pCPT-induced HDAC5 nuclear translocation (Fig. 5D) . These data show that Epac activates translocation of HDAC5 in an IP 3 R and CaMKII dependent manner.
Discussion
The present work demonstrates a novel role for endogenous Epac in cardiac Ca 2+ and hypertrophic signaling. Moreover, the activation of Epac by cAMP in the physiological context, likely coexists with and parallels the classical cAMP-dependent signaling via PKA, but may have very divergent downstream targets. We find that acute activation of endogenous Epac elevates [Ca 2+ ] n and Ca 2+ sparks in a manner that depends on the activation of PLC, IP 3 R and CaMKII. Epac is preferentially located near the nucleus, and acute Epac activation also drives HDAC5 nuclear export (and MEF2 activation) in a manner that is IP 3 R and CaMKII-dependent, paralleling the [Ca 2+ ] n elevation. We propose a working hypothesis for diastolic [Ca 2+ ] schematized in Figure 6 whereby Epac activation can activate PLC, causing DAG and IP 3 production, that the IP 3 activates Ca 2+ release via IP 3 R which result in local activation of CaMKII. This CaMKII activation may then be responsible for the phosphorylation of both RyR (enhancing Ca 2+ sparks and unloading the SR) and HDAC5 (resulting in nuclear HDAC5 export and derepression of MEF2-dependent hypertrophic transcription). Not all of the details of these two Epac-dependent pathways are fully worked out yet (see below), but this represents a novel paradigm in cAMP-dependent Ca 2+ signaling in cardiac myocytes that influences both EC coupling and ET coupling.
Epac activates Ca 2+ release from the SR
We previously showed in rat cardiac myocytes that Epac enhances diastolic SR Ca 2+ release by increasing Ca 2+ spark frequency, and that this required CaMKII activation and RyR phosphorylation at Ser2815, without significant effects on L-type Ca 2+ current (I Ca ) or Ca 2+ removal via Na + /Ca 2+ exchange. [3] Others have also seen that β-adrenergic agonists can activate RyR-mediated leak by CaMKII-dependent and PKA-independent pathways. [26] We also used this strategy to activate native Epac with isoproterenol in the absence of PKA activity. Data presented in Supplementary Fig. S5 shows that β-adrenergic stimulation with isoproterenol in the presence of a PKA inhibitor, KT5722 is able to significantly increase cytosolic and nuclear [Ca 2+ ]. The Epac-induced CaMKII activation [27] , RyR phosphorylation and lack of I Ca modulation were also confirmed by other authors in mouse cardiomyocytes. [23] In adult rat ventricular myocytes, systolic [Ca 2+ ] i transient amplitude is reduced by 8-pCPT, but this did not translate into a negative inotropic effect [3] , because of a parallel increase in myofilament Ca 2+ sensitivity. [28] Moreover, the reduction in the Ca 2+ transient may result from the reduced SR Ca 2+ content (secondary to increased diastolic SR Ca 2+ leak).
Oestreich et al. [19] Here we found that the 8-pCPT-induced increase in both diastolic [Ca 2+ ] i and Ca 2+ sparks depend on PLC, IP 3 Rs and CaMKII. While ventricular IP 3 R type 2 are concentrated at the nuclear envelope, there are some in the SR (especially in atria), where they are known to be able to facilitate the activation RyR-mediated Ca 2+ sparks. [29, 30] The PLC-and CaMKIIdependence we observe here, agrees with results from Oestreich et al. [19, 23] where Epacdependent changes in Ca 2+ handling were also abolished in PLCε knockout mice. While their 8-pCPT effects on Ca 2+ handling were sensitive to PKCε inhibition, our effects reflect activation of the PLC product IP 3 .
This allows a working hypothesis in which Epac-dependent PLC activation causes IP 3 -induced Ca 2+ release that can activate CaMKII, which is known to associate with the IP 3 R. CaMKII can then phosphorylate the RyR to facilitate Ca 2+ release. Indeed, CaMKII can enhance RyR activation both at rest and during EC coupling. [31, 32] An important remaining question is how and where Epac activation causes PLC activation in adult rat cardiac myocytes.
Nuclear Ca 2+ signaling activated by Epac
The Epac effects on Ca 2+ signaling were more prominent on diastolic [Ca 2+ ] n than [Ca 2+ ] i (a 45 vs 28% increase with respect to control). In addition, Epac activation also increased the peak systolic [Ca 2+ ] n by 22%, whereas peak systolic [Ca 2+ ] i was reduced by 9%. The simplest interpretation of this result is that the very much higher density of IP 3 R at the nuclear envelope vs. SR in ventricular myocytes allows the Epac-dependent IP 3 signal to directly raise [Ca 2+ ] n (potentially aided by CaMKII-dependent activation of sparse nuclear envelope RyRs). This may be further accentuated by the preferential perinuclear location of endogenous Epac (Fig. 4) . These localization data confirm previous findings with Epac overexpression in cardiomyocytes [5] , and also the finding that Epac is part of a musclespecific A-Kinase Anchoring Protein (m-AKAP) complex localized in the nuclear envelope of neonatal cardiac myocytes. [33] The higher diastolic [Ca 2+ ] n may also partly explain why peak systolic [Ca 2+ ] n is increased despite the reduction in peak systolic [Ca 2+ ] i . That is, the bolstered baseline allows even a slightly reduced SR Ca 2+ release signal to raise [Ca 2+ ] n to a higher level. In addition, the sensitization of nuclear IP 3 R upon Epac stimulation could amplify the RyR dependent release. Additionally, in the presence of IP 3 , the IP 3 R2 is activated by increased [Ca 2+ ] [34] . This sort of enhancement of nuclear Ca 2+ transients has been reported before during agonist stimulation that increases IP 3 production. [24] . Although the 2-APB is not a completely specific IP 3 R blocker, the involvement of IP 3 R is further supported by the fact that PLC is identified as an upstream element in the Epac signaling cascade (effects are blocked by U73122) and by the finding that 8-pCPT treatment increases IP 3 content.
Nuclear Ca 2+ in the vicinity of the IP 3 R has been shown to modulate transcription factors, dependent at least in part by CaMKII-dependent HDAC5 phosphorylation in ET coupling. [2] Our results here would be consistent with Epac feeding in to the same nuclear IP 3 RCaMKII pathway to activate HDAC5 nuclear export and the prohypertrophic transcription factor MEF2. Indeed, the 8-pCPT-induced HDAC5 nuclear export is prevented by either IP 3 R or CaMKII inhibition (Fig. 5) . This pathway may also provide a mechanistic basis for our previous findings that Epac induces cardiomyocyte hypertrophy. [4, 5] Epac has also been reported to be part of a perinuclear m-AKAP complex, which might also be an important locus for Epac induced cardiac myocyte hypertrophy. [35] Taking together, these data demonstrate that Epac has a role on ET coupling.
The proposed signaling cascade is schematized in Figure 6 . Epac activation of PLC induces IP 3 production, which activates IP 3 R, releasing Ca 2+ into the nucleus and also activating RyRs in the SR. The Ca 2+ released by IP 3 Rs activates CaMKII, which can phosphorylate RyRs to increase Ca 2+ spark occurrence, and also HDAC5 to induce its translocation out of the nucleus derepressing MEF2 transcriptional activity and thereby initiating a prohypertrophic signaling.
In summary, we have identified a role of Epac on both EC and ET coupling, and involving the activation of PLC, IP 3 Rs and CaMKII with effects on RyR gating and nuclear transcription. In this way, the well-known second messenger cAMP may exert actions that are parallel to, but independent of the traditional cAMP-PKA pathway. This alternative pathway must be considered in future studies of cAMP-dependent effects on both EC and ET coupling, and cardiac pathophysiological mechanisms.
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